State of the art overview

ULTRAPLACAD is continuously analysing State of the Art in the field of liquid biopsy, colorectal cancer, DNA and miRNA testing, plasmonic detection, NESPRI and PEFSI, microfluidics, chips, assays, in-vitro diagnosis instrument, etc. Below the list of our references:

“Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers”, D.O.I.: http://dx.doi.org/10.1371/journal.pone.0047020
“Variability in microRNA recovery from plasma: Comparison of five commercial kits”, D.O.I.: 10.1016/j.ab.2015.07.018
“Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?”, D.O.I.: 10.1158/0008-5472.CAN-13-2030
“Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer”, D.O.I.: 10.1002/ijc.28946
“New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?”, D.O.I.: 10.18632/oncotarget.4959
“Amplified plasmonic detection of DNA hybridization using doxorubicin-capped gold particles”, D.O.I.: 10.1039/C3AN01794J
“Bioanalytical approaches for the detection of single nucleotide polymorphisms by Surface Plasmon Resonance biosensors”, D.O.I.: 10.1016/j.bios.2014.04.052
“Plasmon-enhanced fluorescence: the role of field confinement”, D.O.I.: 10.1007/s11468-013-9660-5
“Direct Detection of Point Mutations in Non-amplified Human Genomic DNA”, D.O.I.: 10.1021/ac2021932
“Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer”, D.O.I.: 10.1007/s00216-016-9806-3
“Direct Detection of Point Mutations in Nonamplified Human Genomic DNA”, D.O.I.: dx.doi.org/10.1021/ac2021932
“Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers”, D.O.I.: 10.1038/bjc.2015.303
“Colon cancer diagnostic method and Means: European Patent Application EP13158199”
“The Prostate Cancer Immunome: In Silico Functional Analysis of Antigenic Proteins from Microarray Profiling with IgG.”, D.O.I.: 10.1002/pmic.201500378